Similar Articles
1591 Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation
1592 Liver resection in hepatitis B related-hepatocellular carcinoma: Clinical outcomes and safety in elderly patients
1593 Prognostic factors for hepatocellular carcinoma recurrence
1594 Occult hepatitis B virus and hepatocellular carcinoma
1595 miR-106b-25/miR-17-92 clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma
1596 MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: Current status and future prospects
1597 Value of radiofrequency ablation in the treatment of hepatocellular carcinoma
1598 Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma
1599 Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma
1600 Donor transmitted and de novo cancer after liver transplantation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA